CAH Stock Recent News
CAH LATEST HEADLINES
Cardinal Health Inc.'s stock CAH, +1.91% rose 5% early Wednesday, after the drug distributor and medical products maker beat estimates for the second quarter and raised its guidance. Dublin, Ohio-based Cardinal Health had net income of $235 million, or 96 cents a share, for the quarter, after a loss of $56 million, or 22 cents a share, in the year-earlier period.
Fourth quarter revenue increased 12% to $59.9 billion Fourth quarter GAAP1 operating earnings were $401 million and GAAP diluted EPS was $0.96 Fourth quarter non-GAAP operating earnings increased 14% to $605 million and non-GAAP diluted EPS increased 29% to $1.84 Fiscal Year 2024 operating cash flow and adjusted free cash flow reached all-time highs of $3.8 billion and $3.9 billion, respectively Fiscal year 2025 non-GAAP EPS guidance raised to $7.55 to $7.70, from at least $7.50 DUBLIN, Ohio , Aug. 14, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported fourth quarter fiscal year 2024 revenues of $59.9 billion, an increase of 12% from the prior year. GAAP operating earnings were $401 million and GAAP diluted earnings per share (EPS) were $0.96.
Cardinal Health, Inc. CAH is set to release earnings results for its fourth quarter, before the opening bell on Aug. 14, 2024.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Cardinal Health (CAH) gains from a solid pharmaceutical segment and a diversified product portfolio. However, regulatory setbacks are a concern.
Cardinal Health's (CAH) fourth-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
Cardinal Health, Inc. CAH expects to release earnings results for its fourth quarter, before the opening bell on Wednesday, Aug. 14.
Beyond analysts' top -and-bottom-line estimates for Cardinal (CAH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.
Cardinal (CAH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cardinal Health (CAH) closed at $99.52 in the latest trading session, marking a +1.18% move from the prior day.